$4,580.75 consulting Payment -- Johnson & Johnson to Dr. Timothy Rogers

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

This payment of $4580.75 from Johnson & Johnson to Dr. Timothy Rogers, a General Surgeon, on June 25, 2024, was for consulting services related to Ibrance. Ibrance is a medication primarily used to treat certain types of breast cancer. Consulting fees are common in the pharmaceutical industry, where companies seek expert advice from physicians on drug development, clinical trials, and market insights. The amount, while significant, is not unusually high for specialized consulting work in medicine, especially for physicians with expertise in oncology-related treatments, even if their primary specialty is General Surgery. Potential conflict of interest considerations arise because Dr. Rogers, as a General Surgeon, might be involved in prescribing or recommending treatments, including those related to cancer, or might influence patient care decisions where Ibrance could be relevant. When a physician receives payments from a drug manufacturer, it's important to consider whether this relationship could subtly influence their medical judgment or prescribing habits. The Sunshine Act aims to bring transparency to these relationships, allowing patients to be informed. Comparing this to industry averages is complex, as payment amounts vary widely based on the type of service, the physician's expertise, and the company's needs. However, this single payment for consulting is within a range that many physicians might receive for providing expert advice. It's crucial for patients to understand that such payments do not automatically imply wrongdoing or that a doctor's care is compromised. Instead, it highlights a professional relationship that patients should be aware of and feel comfortable discussing with their physician.

Patient Guidance: What This Payment Means for You

It's understandable to feel curious or concerned when you see your doctor has received payments from pharmaceutical companies. This payment to Dr. Rogers was for consulting, meaning he likely provided expert advice to Johnson & Johnson, possibly related to Ibrance. Transparency laws like the Sunshine Act are designed to help you understand these relationships. While payments don't automatically mean your doctor's decisions are influenced, it's always wise to be informed. If you have questions, you can directly ask your doctor about their relationship with pharmaceutical companies and how they ensure their prescribing decisions are based solely on patient needs and evidence. You might ask, 'I saw that you received a consulting payment from Johnson & Johnson. Could you tell me more about that relationship and how it informs your practice?' Most payments, especially for consulting or speaking, are for legitimate professional services. However, if you notice a pattern of frequent or very large payments, or if your doctor seems overly enthusiastic about a specific drug without clear clinical justification, it might warrant further consideration. Ultimately, open communication is key to maintaining trust in your healthcare.

Payment Context: Is This Amount Normal?

Payments to physicians in specialties like General Surgery can vary widely. Consulting fees, especially for specialized knowledge related to specific drugs or devices, can range from a few hundred to several thousand dollars per engagement. While General Surgeons primarily focus on surgical procedures, some may have expertise or involvement in areas where drugs like Ibrance are used, leading to consulting opportunities. A significant percentage of physicians across various specialties receive some form of payment from the industry, making this type of engagement not uncommon.

Regulatory Context: Sunshine Act Requirements

The Sunshine Act, part of the Affordable Care Act, requires manufacturers of drugs and medical devices to report payments and other transfers of value made to physicians and teaching hospitals. This specific payment, a consulting fee of $4580.75, exceeds the reporting threshold and must be publicly disclosed on the CMS Open Payments database. These disclosures are intended to increase transparency. While consulting is a legitimate activity, the Act aims to allow patients and the public to scrutinize these financial relationships.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharma-payments
• sunshine-act
• consulting-fee
• johnson-and-johnson
• ibrance
• general-surgery
• conflict-of-interest

Understanding consulting Payments

Consulting payments are made when pharmaceutical companies hire physicians as advisors or consultants. This can include serving on advisory boards, providing expert medical opinions on drug development or marketing strategies, and reviewing clinical data. Consulting is one of the most common forms of pharmaceutical payment to physicians and can range from a few hundred dollars for a brief consultation to tens of thousands of dollars for ongoing advisory relationships.

Frequently Asked Questions About This Payment

Does my doctor take pharma money?

You can check if your doctor receives payments from pharmaceutical or medical device companies through the Centers for Medicare & Medicaid Services (CMS) Open Payments database. This database is publicly accessible and allows you to search for physicians by name or NPI number. It lists payments made for various reasons, such as consulting, speaking, meals, or research. Seeing that a doctor receives payments doesn't automatically mean their care is compromised, but it provides transparency about potential professional relationships that could influence their practice. It's a tool to foster informed discussions between patients and their doctors.

Should I worry about this payment?

This specific payment of $4580.75 to Dr. Rogers for consulting related to Ibrance is a moderate amount for a consulting engagement. While it's important to be aware of any financial ties between your doctor and drug companies, this single payment for consulting doesn't inherently mean your care will be negatively affected. Consulting fees are often for providing expert advice based on clinical experience. However, it's always a good practice to maintain open communication with your doctor about any concerns and to ensure you understand the rationale behind any treatment recommendations.

What types of pharma payments are most concerning?

While all payments are disclosed, certain types of payments may warrant more attention. Large, frequent payments for speaking engagements or consulting, especially if they seem disconnected from genuine expert advice, can raise concerns. Payments for meals or travel, while often smaller, can also create a sense of obligation. Payments tied directly to prescribing volume or sales targets would be highly concerning, though these are generally prohibited. The key is to look at the nature, frequency, and amount of payments in conjunction with the physician's prescribing patterns and the clinical appropriateness of the treatments recommended.

How do I talk to my doctor about pharma relationships?

Start by acknowledging the transparency provided by the Open Payments database. You could say, 'I was looking at the Open Payments data and saw that you've had some consulting relationships with pharmaceutical companies. I'm interested in understanding how these relationships work.' You can then ask specific questions like, 'How do you ensure your prescribing decisions are based solely on patient needs and the latest evidence?' or 'Could you explain the role of [specific drug] in my treatment plan, and if there are other options?' Frame your questions with curiosity rather than accusation to foster a more productive conversation.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for doctors to accept payments from pharmaceutical and medical device companies, provided these payments comply with federal and state laws. The Sunshine Act requires companies to report most payments made to physicians and teaching hospitals, making these relationships transparent. These payments are often for legitimate services like consulting, speaking at educational events, participating in research, or providing expert advice. The key is that these payments should not be inducements for prescribing specific drugs or devices, and the relationships must be disclosed.

Does pharma money affect what my doctor prescribes?

Research suggests that financial relationships between physicians and pharmaceutical companies can influence prescribing habits, though the extent varies. Even small gifts or meals have been shown to subtly affect perceptions and decisions. Consulting fees, especially for expert advice, are intended to be based on knowledge, but the financial tie can create a bias. It's important to remember that most physicians strive to act in their patients' best interests. However, being aware of these potential influences allows you to have more informed discussions with your doctor about treatment options and to seek second opinions if needed.

How does this compare to other doctors in this specialty?

General Surgeons, as a specialty, see a range of payments. While many General Surgeons may not receive direct payments related to specific drugs like Ibrance, those who engage in research, consulting, or have sub-specialties that intersect with pharmaceuticals (like surgical oncology) might receive payments. The average payment amount can vary significantly, but a single consulting fee of this size is not uncommon for physicians providing specialized expertise. The percentage of General Surgeons receiving payments is likely lower than for specialties more directly involved in prescribing medications, but it's not negligible.

Related Reports

• View Dr. Timothy Rogers's full payment report
• Johnson & Johnson full spending report
• Browse all General Surgery payments
• Browse all payments in Virginia
• Search for other payments